Clinical Trial

Imagery as Biomarker of Gout

Study acronym: TIGER
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
The objective of this study is to determine whether MSU crystal deposits visualized on ultrasound and/or DECT are associated with the development of symptomatic gout (according to ACR 2015 / EULAR criteria) over 5 years in hyperuricemic individuals.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2022-06-27; most recent amendment 2025-09-03.
Status change: Recruiting → Active, Not Recruiting 2025-09-03
Status change: Not Yet Recruiting → Recruiting 2022-11-28
Trial Details
NCT Number NCT05434858
Lead Sponsor Lille Catholic University
Collaborators: Auckland University
Conditions Hyperuricemia
Enrollment 21 participants
Start Date 2022-09-09
Primary Completion 2024-08-31 (estimated)
Study Completion 2029-09-09 (estimated)
Updated on ClinicalTrials.gov 2025-09-10